[
    {
        "question_id": "10510_B_276",
        "new_question_id": "26594",
        "question_type": "0",
        "category": "9",
        "concept_id_link": "4140",
        "notes_id_link": "1_1683",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Clomipramine",
            "Diazepam",
            "Mirtazapine",
            "Risperidone",
            "Venlafaxine",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 33-year-old man was diagnosed with post-traumatic stress disorder (PTSD) 6 months ago. He has been engaging well with cognitive behavioural therapy (CBT) but is still experiencing significant symptoms.<br /><br />Which of the following would be the most appropriate medication to prescribe?",
            "",
            ""
        ],
        "answers": [
            "5",
            "0",
            "0"
        ],
        "notes": [
            "The correct answer is venlafaxine.<br /><br />Given that this patient has tried CBT with little benefit the next step would be medication. The first-line medication to try would be a serotonin-norepinephrine reuptake inhibitor (SNRI) such as venlafaxine, or a selective serotonin reuptake inhibitor.<br /><br />Clomipramine is a tricyclic antidepressant (TCA) and is not recommended for the treatment of PTSD.<br /><br />Diazepam is a benzodiazepine and not recommended in the treatment of PTSD. It can cause tolerance and addiction.<br /><br />Mirtazapine is an antidepressant with multiple effects, it is often described as a noradrenergic and specific serotonergic antidepressant (NaSSA). It has many uses but is not generally recommended in the treatment of PTSD.<br /><br />Risperidone is an anti-psychotic that may be used in severe cases of PTSD. However, it would not be an appropriate first-line medication for this patient.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 33-year-old man was diagnosed with post-traumatic stress disorder (PTSD) 6 months ago. He has been engaging well with cognitive behavioural therapy (CBT) but is still experiencing significant symptoms.<br /><br />Which of the following would be the most appropriate medication to prescribe?",
        "correct_answer": "5",
        "question_notes": "The correct answer is venlafaxine.<br /><br />Given that this patient has tried CBT with little benefit the next step would be medication. The first-line medication to try would be a serotonin-norepinephrine reuptake inhibitor (SNRI) such as venlafaxine, or a selective serotonin reuptake inhibitor.<br /><br />Clomipramine is a tricyclic antidepressant (TCA) and is not recommended for the treatment of PTSD.<br /><br />Diazepam is a benzodiazepine and not recommended in the treatment of PTSD. It can cause tolerance and addiction.<br /><br />Mirtazapine is an antidepressant with multiple effects, it is often described as a noradrenergic and specific serotonergic antidepressant (NaSSA). It has many uses but is not generally recommended in the treatment of PTSD.<br /><br />Risperidone is an anti-psychotic that may be used in severe cases of PTSD. However, it would not be an appropriate first-line medication for this patient.",
        "answer_order": "5",
        "answer": "5",
        "title": "Post-traumatic stress disorder",
        "body": "Post-traumatic stress disorder (PTSD) can develop in people of any age following a traumatic event, for example, a major disaster or childhood sexual abuse. It encompasses what became known as 'shell shock' following the first world war. One of the DSM-IV diagnostic criteria is that symptoms have been present for more than <span class=\"concept\" data-cid=\"8329\">one month</span>.<br /><br /><span class=\"concept\" data-cid=\"9919\">Features</span><br /><ul><li>re-experiencing: <span class=\"concept\" data-cid=\"6394\">flashbacks</span>, nightmares, repetitive and distressing intrusive images </li><li>avoidance: avoiding people, situations or circumstances resembling or associated with the event</li><li>hyperarousal: hypervigilance for threat, exaggerated startle response, sleep problems, irritability and difficulty concentrating</li><li>emotional numbing - lack of ability to experience feelings, feeling detached</li></ul>from other people<br /><ul><li>depression</li><li>drug or alcohol misuse</li><li>anger</li><li>unexplained physical symptoms</li></ul><br />Management<br /><ul><li>following a traumatic event single-session interventions (often referred to as debriefing) are not recommended</li><li><span class=\"concept\" data-cid=\"2389\">watchful waiting</span> may be used for mild symptoms lasting less than 4 weeks</li><li>military personnel have access to treatment provided by the armed forces</li><li><span class=\"concept\" data-cid=\"3305\">trauma-focused cognitive behavioural therapy</span> (CBT) or eye movement desensitisation and reprocessing (EMDR) therapy may be used in more severe cases</li><li><span class=\"concept\" data-cid=\"3753\">drug treatments</span> for PTSD should not be used as a routine first-line treatment for adults. If drug treatment is used then <span class=\"concept\" data-cid=\"4140\">venlafaxine or a selective serotonin reuptake inhibitor (SSRI)</span>, such as sertraline should be tried. In severe cases, NICE recommends that risperidone may be used</li></ul>",
        "notes_hash": "49aff489c5e34720ab598997d5cd2944",
        "knowledge_graph_node_id_link": 11263,
        "concept": "If CBT or EMDR therapy are ineffective in PTSD, the first line drug treatments are venlafaxine or a SSRI",
        "concept_percentile": "94",
        "concept_colour": "rgb(30,255,0)",
        "number_attempts": "5861",
        "up_votes": "17",
        "down_votes": "11",
        "column_array": [
            0,
            "380",
            "284",
            "1350",
            "387",
            "3460",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_914\" data-linkid=\"914\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_914\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">16</span><button type=\"button\" style=\"\" id=\"link_dislike_914\" data-linkid=\"914\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_914\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">20</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng116/chapter/Recommendations\">2018 PTSD guidelines</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/hzSx4rMyVjI\" data-description=\"Post-traumatic Stress Disorder (PTSD)\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"324\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/hzSx4rMyVjI/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/hzSx4rMyVjI\" data-description=\"Post-traumatic Stress Disorder (PTSD)\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"324\">Post-traumatic Stress Disorder (PTSD)</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_550\" data-mediaid=\"550\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_550\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_550\" data-mediaid=\"550\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_550\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/yKQTB3CG-yI\" data-description=\"Post-traumatic stress disorder\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1365\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/yKQTB3CG-yI/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/yKQTB3CG-yI\" data-description=\"Post-traumatic stress disorder\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1365\">Post-traumatic stress disorder</a></td></tr><tr><td><span ><small>Rhesus Medicine - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2397\" data-mediaid=\"2397\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2397\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_2397\" data-mediaid=\"2397\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2397\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr></table>",
        "comment_count": 3,
        "concepts_for_notes": {
            "3305": {
                "concept_text": "PTSD management - trauma-focused cognitive behavioural therapy or EMDR",
                "concept_percentile": "37"
            },
            "4140": {
                "concept_text": "If CBT or EMDR therapy are ineffective in PTSD, the first line drug treatments are venlafaxine or a SSRI",
                "concept_percentile": "94"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_617",
        "new_question_id": "11006",
        "question_type": "0",
        "category": "6",
        "concept_id_link": "942",
        "notes_id_link": "1_934",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Sore throat",
            "Heartburn",
            "Headache",
            "Diarrhoea",
            "Palpitations",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 72-year-old female known to have osteoporosis is started on alendronate. Which one of the following side-effects is it most important to warn her about?",
            "",
            ""
        ],
        "answers": [
            "2",
            "",
            ""
        ],
        "notes": [
            "Whilst the development of any new problem following the introduction of a new drug warrants medical review it is particularly important to warn patients starting bisphosphonates about symptoms which could suggest an oesophageal reaction, especially with alendronate",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 72-year-old female known to have osteoporosis is started on alendronate. Which one of the following side-effects is it most important to warn her about?",
        "correct_answer": "2",
        "question_notes": "Whilst the development of any new problem following the introduction of a new drug warrants medical review it is particularly important to warn patients starting bisphosphonates about symptoms which could suggest an oesophageal reaction, especially with alendronate",
        "answer_order": "2",
        "answer": "2",
        "title": "Bisphosphonates",
        "body": "Bisphosphonates are analogues of pyrophosphate, a molecule which decreases demineralisation in bone. They <span class=\"concept\" data-cid=\"943\">inhibit osteoclasts</span> by reducing recruitment and promoting apoptosis.<br /><br />Clinical uses<br /><ul><li>prevention and treatment of osteoporosis</li><li>hypercalcaemia</li><li>Paget's disease</li><li>pain from bone metatases</li></ul><br />Adverse effects<br /><ul><li><span class=\"concept\" data-cid=\"942\">oesophageal reactions</span>: oesophagitis, oesophageal ulcers (especially alendronate)</li><li><span class=\"concept\" data-cid=\"2633\">osteonecrosis of the jaw</span><ul><li>substantially greater risk for patients receiving <span class=\"concept\" data-cid=\"12114\">IV bisphosphonates in the treatment</span> of cancer than for patients receiving oral bisphosphonates for osteoporosis or Paget's disease</li><li>poor dental hygiene/prior dental procedures are also a risk factor</li><li>the BNF advises that <i>'all patients with cancer and patients with poor dental status should have a <span class=\"concept\" data-cid=\"12209\">dental check-up</span> ... before bisphosphonate treatment'</i></li><li>initial investigation of choice if suspected would be an <span class=\"concept\" data-cid=\"12534\">orthopantomogram</span> - also known as a panoramic dental X-ray</li></ul></li><li>increased risk of <span class=\"concept\" data-cid=\"7993\">atypical stress fractures</span> of the proximal femoral shaft in patients taking alendronate</li><li>acute phase response: fever, myalgia and arthralgia may occur following administration</li><li>hypocalcaemia: due to reduced calcium efflux from bone. Usually clinically unimportant</li></ul><br />The <span class=\"concept\" data-cid=\"11782\">BNF suggests the following counselling for patients taking oral bisphosphonates</span><br /><ul><li>'Tablets should be swallowed whole with plenty of water while sitting or standing; to be given on an empty stomach at least 30 minutes before breakfast (or another oral medication); patient should stand or sit upright for at least 30 minutes after taking tablet'</li></ul><br /><span class=\"concept\" data-cid=\"10439\">Hypocalcemia/vitamin D deficiency should be corrected before giving bisphosphonates</span>. However, when starting bisphosphonate treatment for osteoporosis, <span class=\"concept\" data-cid=\"9560\">calcium should only be prescribed if dietary intake is inadequate</span>. Vitamin D supplements are normally given.<br /><br />The duration of bisphosphonate treatment varies according to the level of risk. Some authorities recommend stopping bisphosphonates at 5 years if the following apply:<br /><ul><li>patient is < 75-years-old</li><li>femoral neck T-score of > -2.5</li><li>low risk according to FRAX/NOGG</li></ul>",
        "notes_hash": "e6a9681d0b618cc385dcfc1d45ecdd5e",
        "knowledge_graph_node_id_link": 10848,
        "concept": "Bisphosphonates can cause a variety of oesophageal problems",
        "concept_percentile": "33",
        "concept_colour": "rgb(255,168,0)",
        "number_attempts": "4660",
        "up_votes": "21",
        "down_votes": "10",
        "column_array": [
            0,
            "298",
            "3901",
            "50",
            "334",
            "77",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>BNF</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1590\" data-linkid=\"1590\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1590\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">19</span><button type=\"button\" style=\"\" id=\"link_dislike_1590\" data-linkid=\"1590\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1590\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">12</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://bnf.nice.org.uk/treatment-summary/osteoporosis.html\">Osteoporosis</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/DBZIBFC8ang\" data-description=\"Osteoporosis pharmacology, prevention and treatment\" data-upvotes=\"0\" data-downvotes=\"3\" data-media=\"1279\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/DBZIBFC8ang/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/DBZIBFC8ang\" data-description=\"Osteoporosis pharmacology, prevention and treatment\" data-upvotes=\"0\" data-downvotes=\"3\" data-media=\"1279\">Osteoporosis pharmacology, prevention and treatment</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2261\" data-mediaid=\"2261\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2261\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_2261\" data-mediaid=\"2261\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2261\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr></table>",
        "comment_count": 1,
        "concepts_for_notes": {
            "942": {
                "concept_text": "Bisphosphonates can cause a variety of oesophageal problems",
                "concept_percentile": "33"
            },
            "2633": {
                "concept_text": "Bisphosphonates can cause osteonecrosis of the jaw",
                "concept_percentile": "10"
            },
            "9560": {
                "concept_text": "When starting bisphosphonate treatment for osteoporosis, calcium should only be prescribed if dietary intake is inadequate",
                "concept_percentile": "80"
            },
            "10439": {
                "concept_text": "Hypocalcemia/vitamin D deficiency should be corrected before giving bisphosphonates",
                "concept_percentile": "93"
            },
            "11782": {
                "concept_text": "Oral bisphosphonates should be swallowed with plenty of water while sitting or standing on an empty stomach at least 30 minutes before breakfast (or another oral medication); the patient should stand or sit upright for at least 30 minutes after taking",
                "concept_percentile": "46"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1865",
        "new_question_id": "6874",
        "question_type": "0",
        "category": "8",
        "concept_id_link": "0",
        "notes_id_link": "1_2280",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "G6PD deficiency",
            "Asthma (requiring inhaled corticosteroids)",
            "A history of anxiety or depression",
            "Combined oral contraceptive pill use",
            "A family history of venous thromboembolism",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "You are considering prescribing mefloquine as malarial prophlaxis for a 25-year-old woman. Which one of the following is the most important contraindication to consider?",
            "",
            ""
        ],
        "answers": [
            "3",
            "",
            ""
        ],
        "notes": [
            "The correct answer is <b>A history of anxiety or depression</b>. Mefloquine, an antimalarial medication, has been linked to neuropsychiatric side effects such as anxiety and depression. According to UK guidelines, mefloquine should not be prescribed for individuals with a history of psychiatric disorders including anxiety and depression. This is due to the risk of exacerbation of these conditions.<br /><br />The option <b>G6PD deficiency</b> is incorrect. Glucose-6-phosphate dehydrogenase (G6PD) deficiency can cause haemolysis in response to certain drugs, infections, or other stressors. However, mefloquine is not known to cause haemolysis in G6PD-deficient individuals and thus it's safe to use in this population.<br /><br /><b>Asthma (requiring inhaled corticosteroids)</b> is also not a contraindication for mefloquine use. There's no evidence suggesting that mefloquine would exacerbate asthma symptoms or interact negatively with inhaled corticosteroids.<br /><br /><b>Combined oral contraceptive pill use</b> does not preclude the use of mefloquine either. While some medications can reduce the effectiveness of hormonal contraceptives, mefloquine is not one of them.<br /><br />Finally, <b>a family history of venous thromboembolism</b> would not deter from prescribing mefloquine. Antimalarial drugs like mefloquine are not associated with increased clotting risk and hence they can be used safely even if there's a family history of venous thromboembolism.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "You are considering prescribing mefloquine as malarial prophlaxis for a 25-year-old woman. Which one of the following is the most important contraindication to consider?",
        "correct_answer": "3",
        "question_notes": "The correct answer is <b>A history of anxiety or depression</b>. Mefloquine, an antimalarial medication, has been linked to neuropsychiatric side effects such as anxiety and depression. According to UK guidelines, mefloquine should not be prescribed for individuals with a history of psychiatric disorders including anxiety and depression. This is due to the risk of exacerbation of these conditions.<br /><br />The option <b>G6PD deficiency</b> is incorrect. Glucose-6-phosphate dehydrogenase (G6PD) deficiency can cause haemolysis in response to certain drugs, infections, or other stressors. However, mefloquine is not known to cause haemolysis in G6PD-deficient individuals and thus it's safe to use in this population.<br /><br /><b>Asthma (requiring inhaled corticosteroids)</b> is also not a contraindication for mefloquine use. There's no evidence suggesting that mefloquine would exacerbate asthma symptoms or interact negatively with inhaled corticosteroids.<br /><br /><b>Combined oral contraceptive pill use</b> does not preclude the use of mefloquine either. While some medications can reduce the effectiveness of hormonal contraceptives, mefloquine is not one of them.<br /><br />Finally, <b>a family history of venous thromboembolism</b> would not deter from prescribing mefloquine. Antimalarial drugs like mefloquine are not associated with increased clotting risk and hence they can be used safely even if there's a family history of venous thromboembolism.",
        "answer_order": "3",
        "answer": "3",
        "title": "Mefloquine",
        "body": "Mefloquine (brand name Lariam) is used for both the prophylaxis and treatment of certain types of malaria. There has long been a concern about the neuropsychiatric side-effects of mefloquine. A recent review has however led to 'strengthened warnings' about the potential risks.<br /><br />The following advice is therefore given:<br /><ul><li>certain side-effects such nightmares or anxiety may be 'prodromal' of a more serious neuropsychiatric event</li><li>suicide and deliberate self harm have been reported in patients taking mefloquine</li><li>adverse reactions may continue for several months due to the long half-life or mefloquine</li><li>mefloquine should not be used in patients with a history of anxiety, depression schizophrenia or other psychiatric disorders</li><li>patients who experience neuropsychiatric sife-effects should stop mefloquine and seek medical advice</li></ul>",
        "notes_hash": "e463fbe8c5c053105d73ce6ff7398672",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "4372",
        "up_votes": "0",
        "down_votes": "1",
        "column_array": [
            0,
            "2532",
            "117",
            "929",
            "546",
            "248",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Medicines and Healthcare products Regulatory Agency</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_465\" data-linkid=\"465\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_465\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"link_dislike_465\" data-linkid=\"465\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_465\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON336723\">November 2013 Drug Safety Update</a></td></tr></table>",
        "media": "",
        "comment_count": 8,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "16300_B_1035",
        "new_question_id": "33889",
        "question_type": "0",
        "category": "7",
        "concept_id_link": "11483",
        "notes_id_link": "1_1450",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Perform an oral challenge",
            "Refer to a paediatrician",
            "Switch to an amino acid-based formula",
            "Switch to an extensive hydrolysed formula",
            "Switch to breastfeeding",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 6-week-old baby boy presents to his GP with symptoms of regurgitation and vomiting after feeding. His mother also reports ongoing issues with diarrhoea. He is generally irritable; his mother has also noticed some dry patches of skin on the insides of his elbows. The mother reports that he is formula-fed.<br /><br />His examination is unremarkable aside from mild eczema of the elbow flexures. Reassuringly, he is an appropriate size and weight for his age.<br /><br />What is the most appropriate next step?",
            "",
            ""
        ],
        "answers": [
            "4",
            "0",
            "0"
        ],
        "notes": [
            "This baby is demonstrating signs of cow's milk protein intolerance/allergy, which occurs in 3-6% of all children, usually within the first 3 months of life. Given that he is an appropriate size and weight for his age, this can be considered a mild-moderate case. As such, it can initially be managed in primary care; the first step would be to <b>switch to an extensive hydrolysed formula</b>.<br /><br /><b>Performing an oral challenge</b> would be inappropriate; this is performed in the hospital setting and is usually reserved for cases where there is significant diagnostic doubt and for determining whether a food allergy has resolved.<br /><br /><b>Referral to a paediatrician</b> is unnecessary at this stage. Given that the symptoms are mild-moderate, the patient can be tried on an extensive hydrolysed formula first.<br /><br />If the initial switch to an extensive hydrolysed formula does not alleviate symptoms at all, a <b>switch to an amino acid-based formula</b> can be tried.<br /><br />It would be inappropriate to advise the mother to <b>switch to breastfeeding</b>. She may not be comfortable in doing so or may be unable to do so. For whatever reason, she has chosen to formula-feed her baby and this decision should be respected. A very small proportion of exclusively-breastfed babies are also cow's milk protein intolerant - for these patients, the mother should be advised to continue breastfeeding and eliminate cow's milk from her own diet.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 6-week-old baby boy presents to his GP with symptoms of regurgitation and vomiting after feeding. His mother also reports ongoing issues with diarrhoea. He is generally irritable; his mother has also noticed some dry patches of skin on the insides of his elbows. The mother reports that he is formula-fed.<br /><br />His examination is unremarkable aside from mild eczema of the elbow flexures. Reassuringly, he is an appropriate size and weight for his age.<br /><br />What is the most appropriate next step?",
        "correct_answer": "4",
        "question_notes": "This baby is demonstrating signs of cow's milk protein intolerance/allergy, which occurs in 3-6% of all children, usually within the first 3 months of life. Given that he is an appropriate size and weight for his age, this can be considered a mild-moderate case. As such, it can initially be managed in primary care; the first step would be to <b>switch to an extensive hydrolysed formula</b>.<br /><br /><b>Performing an oral challenge</b> would be inappropriate; this is performed in the hospital setting and is usually reserved for cases where there is significant diagnostic doubt and for determining whether a food allergy has resolved.<br /><br /><b>Referral to a paediatrician</b> is unnecessary at this stage. Given that the symptoms are mild-moderate, the patient can be tried on an extensive hydrolysed formula first.<br /><br />If the initial switch to an extensive hydrolysed formula does not alleviate symptoms at all, a <b>switch to an amino acid-based formula</b> can be tried.<br /><br />It would be inappropriate to advise the mother to <b>switch to breastfeeding</b>. She may not be comfortable in doing so or may be unable to do so. For whatever reason, she has chosen to formula-feed her baby and this decision should be respected. A very small proportion of exclusively-breastfed babies are also cow's milk protein intolerant - for these patients, the mother should be advised to continue breastfeeding and eliminate cow's milk from her own diet.",
        "answer_order": "4",
        "answer": "4",
        "title": "Cow's milk protein intolerance/allergy",
        "body": "Cow's milk protein intolerance/allergy (CMPI/CMPA) occurs in around 3-6% of all children and typically <span class=\"concept\" data-cid=\"1995\">presents in the first 3 months of life in formula-fed infants</span>, although rarely it is seen in <span class=\"concept\" data-cid=\"1997\">exclusively breastfed infants</span>. <br /><br />Both immediate (IgE mediated) and delayed (non-IgE mediated) reactions are seen. The term CMPA is usually used for immediate reactions and CMPI for mild-moderate delayed reactions.<br /><br />Features<br /><ul><li>regurgitation and vomiting</li><li>diarrhoea</li><li>urticaria, atopic eczema</li><li>'colic' symptoms: irritability, crying</li><li>wheeze, chronic cough</li><li>rarely angioedema and anaphylaxis may occur</li></ul><br />Diagnosis is often clinical (e.g. improvement with cow's milk protein elimination). Investigations include:<br /><ul><li>skin prick/patch testing</li><li>total IgE and specific IgE (RAST) for cow's milk protein</li></ul><br /><h5 class='notes-heading'>Management</h5><br />If the <span class=\"concept\" data-cid=\"1996\">symptoms are severe (e.g. failure to thrive) refer to a paediatrician</span>.<br /><br />Management if formula-fed<br /><ul><li><span class=\"concept\" data-cid=\"11483\">extensive hydrolysed formula</span> (eHF) milk is the first-line replacement formula for infants with mild-moderate symptoms</li><li><span class=\"concept\" data-cid=\"11484\">amino acid-based formula</span> (AAF) in infants with severe CMPA or if no response to eHF</li><li><span class=\"concept\" data-cid=\"1999\">around 10% of infants are also intolerant to soya milk</span></li></ul><br />Management if breastfed<br /><ul><li>continue breastfeeding</li><li>eliminate cow's milk protein from maternal diet. <span class=\"concept\" data-cid=\"9562\">Consider prescribing calcium supplements</span> for breastfeeding mothers whose babies have, or are suspected to have, CMPI, to prevent deficiency whilst they exclude dairy from their diet </li><li>use eHF milk when breastfeeding stops, until 12 months of age and at least for 6 months</li></ul><br /><h5 class='notes-heading'>Prognosis</h5><br />CMPI usually resolves in most children<br /><ul><li>in children with IgE mediated intolerance around 55% will be milk tolerant by the age of 5 years</li><li><span class=\"concept\" data-cid=\"1998\">in children with non-IgE mediated intolerance most children will be milk tolerant by the age of 3 years</span></li><li>a challenge is often performed in the hospital setting as anaphylaxis can occur.</li></ul>",
        "notes_hash": "7c6321794c862ff5912a3b14b581afa5",
        "knowledge_graph_node_id_link": 1233,
        "concept": "If a formula-fed baby is suspected of having mild-moderate cow's milk protein intolerance then a extensive hydrolysed formula should be tried",
        "concept_percentile": "55",
        "concept_colour": "rgb(229,255,0)",
        "number_attempts": "5159",
        "up_votes": "18",
        "down_votes": "25",
        "column_array": [
            0,
            "111",
            "361",
            "358",
            "4136",
            "193",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NHS Choices</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_425\" data-linkid=\"425\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_425\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">12</span><button type=\"button\" style=\"\" id=\"link_dislike_425\" data-linkid=\"425\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_425\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">10</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://www.nhs.uk/conditions/pregnancy-and-baby/pages/types-of-infant-formula.aspx#close\">Types of infant formula</a></td></tr></table>",
        "media": "",
        "comment_count": 9,
        "concepts_for_notes": {
            "1995": {
                "concept_text": "Cows milk protein allergy typically presents in the first 3 months of life in formula-fed infants",
                "concept_percentile": "21"
            },
            "11483": {
                "concept_text": "If a formula-fed baby is suspected of having mild-moderate cow's milk protein intolerance then a extensive hydrolysed formula should be tried",
                "concept_percentile": "55"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1618",
        "new_question_id": "5716",
        "question_type": "0",
        "category": "9",
        "concept_id_link": "0",
        "notes_id_link": "1_1910",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Tramadol",
            "Morphine",
            "Codeine",
            "Oxycodone",
            "Buprenorphine",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "Neuropathic pain characteristically responds poorly to opioids. However, if standard treatment options have failed which opioid is it most appropriate to consider starting?",
            "",
            ""
        ],
        "answers": [
            "1",
            "",
            ""
        ],
        "notes": [
            "The correct answer is <b>Tramadol</b>. Tramadol has a dual mechanism of action, acting as both a weak opioid agonist and a reuptake inhibitor of serotonin and norepinephrine. This unique action profile gives it an edge in managing neuropathic pain compared to other opioids. The UK National Institute for Health and Care Excellence (NICE) guidelines recommend considering tramadol when standard treatment options have failed.<br /><br /><b>Morphine</b>, while being a strong opioid, is not typically the first choice for neuropathic pain. It works primarily on mu-opioid receptors but lacks the additional mechanisms that make tramadol more effective for this type of pain. Furthermore, morphine has a higher risk of side effects such as respiratory depression, constipation, and dependence.<br /><br /><b>Codeine</b> is another opioid that acts on the mu-opioid receptors but it's considered a weaker analgesic compared to morphine and oxycodone. Its efficacy in treating neuropathic pain is limited and it also carries risks of side effects including constipation, nausea, and potential for addiction.<br /><br /><b>Oxycodone</b> shares similar properties with morphine as they both are strong opioids acting primarily on mu-opioid receptors. However, its benefits in neuropathic pain are limited due to a lack of additional mechanisms like those seen with tramadol.<br /><br />Lastly, <b>Buprenorphine</b> is a partial agonist at mu-opioid receptors and an antagonist at kappa-opioid receptors. Though it has been used for chronic pain management, its use in neuropathic pain isn't well-supported by evidence or recommended by NICE guidelines due to its complex pharmacodynamics and high receptor affinity which can complicate the management of acute pain situations or surgical procedures where full opioid agonists may be required.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "Neuropathic pain characteristically responds poorly to opioids. However, if standard treatment options have failed which opioid is it most appropriate to consider starting?",
        "correct_answer": "1",
        "question_notes": "The correct answer is <b>Tramadol</b>. Tramadol has a dual mechanism of action, acting as both a weak opioid agonist and a reuptake inhibitor of serotonin and norepinephrine. This unique action profile gives it an edge in managing neuropathic pain compared to other opioids. The UK National Institute for Health and Care Excellence (NICE) guidelines recommend considering tramadol when standard treatment options have failed.<br /><br /><b>Morphine</b>, while being a strong opioid, is not typically the first choice for neuropathic pain. It works primarily on mu-opioid receptors but lacks the additional mechanisms that make tramadol more effective for this type of pain. Furthermore, morphine has a higher risk of side effects such as respiratory depression, constipation, and dependence.<br /><br /><b>Codeine</b> is another opioid that acts on the mu-opioid receptors but it's considered a weaker analgesic compared to morphine and oxycodone. Its efficacy in treating neuropathic pain is limited and it also carries risks of side effects including constipation, nausea, and potential for addiction.<br /><br /><b>Oxycodone</b> shares similar properties with morphine as they both are strong opioids acting primarily on mu-opioid receptors. However, its benefits in neuropathic pain are limited due to a lack of additional mechanisms like those seen with tramadol.<br /><br />Lastly, <b>Buprenorphine</b> is a partial agonist at mu-opioid receptors and an antagonist at kappa-opioid receptors. Though it has been used for chronic pain management, its use in neuropathic pain isn't well-supported by evidence or recommended by NICE guidelines due to its complex pharmacodynamics and high receptor affinity which can complicate the management of acute pain situations or surgical procedures where full opioid agonists may be required.",
        "answer_order": "1",
        "answer": "1",
        "title": "Neuropathic pain",
        "body": "Neuropathic pain may be defined as pain which arises following damage or disruption of the nervous system. It is often difficult to treat and responds poorly to standard analgesia.<br /><br />Examples include:<br /><ul><li>diabetic neuropathy</li><li>post-herpetic neuralgia</li><li>trigeminal neuralgia</li><li>prolapsed intervertebral disc</li></ul><br />NICE updated their guidance on the management of neuropathic pain in 2013:<br /><ul><li><span class=\"concept\" data-cid=\"9180\">first-line treatment*: amitriptyline, duloxetine, gabapentin or pregabalin</span><ul><li><span class=\"concept\" data-cid=\"9180\">if the first-line drug treatment does not work try one of the other 3 drugs</span></li><li>in contrast to standard analgesics, drugs for neuropathic pain are typically used as monotherapy, i.e. <span class=\"concept\" data-cid=\"11066\">if not working then drugs should be switched, not added</span></li></ul></li><li>tramadol may be used as 'rescue therapy' for exacerbations of neuropathic pain</li><li>topical capsaicin may be used for localised neuropathic pain (e.g. post-herpetic neuralgia)</li><li>pain management clinics may be useful in patients with resistant problems</li></ul><br />*please note that for some specific conditions the guidance may vary. For example carbamazepine is used first-line for trigeminal neuralgia",
        "notes_hash": "169873c98e8cdeed571f071bbda3e9f0",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "4565",
        "up_votes": "23",
        "down_votes": "19",
        "column_array": [
            0,
            "2748",
            "228",
            "392",
            "268",
            "929",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_210\" data-linkid=\"210\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_210\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">12</span><button type=\"button\" style=\"\" id=\"link_dislike_210\" data-linkid=\"210\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_210\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/cg173/chapter/1-Recommendations\">2013 Neuropathic pain guidelines</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/MH5UxisYm9I\" data-description=\"Understanding The Causes of Pain and Pain Management\" data-upvotes=\"4\" data-downvotes=\"0\" data-media=\"1327\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/MH5UxisYm9I/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/MH5UxisYm9I\" data-description=\"Understanding The Causes of Pain and Pain Management\" data-upvotes=\"4\" data-downvotes=\"0\" data-media=\"1327\">Understanding The Causes of Pain and Pain Management</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2347\" data-mediaid=\"2347\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2347\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">4</span><button type=\"button\" style=\"\" id=\"media_dislike_2347\" data-mediaid=\"2347\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2347\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr></table>",
        "comment_count": 3,
        "concepts_for_notes": {
            "11066": {
                "concept_text": "Drugs for neuropathic pain are typically used as monotherapy, i.e. if not working then drugs should be switched, not added",
                "concept_percentile": "93"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1421",
        "new_question_id": "5458",
        "question_type": "0",
        "category": "10",
        "concept_id_link": "0",
        "notes_id_link": "1_1865",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Nebulised salbutamol",
            "Intravenous bicarbonate",
            "Haemodialysis",
            "Insulin/dextrose infusion",
            "Intravenous calcium gluconate",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 45-year-old man is seen in the Emergency Department with nausea, pallor and lethargy. He has no past medical history of note. A cannula is inserted and bloods show the following<br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>Na<sup>+</sup></td><td>140 mmol/l</td></tr><tr><td>K<sup>+</sup></td><td>6.7 mmol/l</td></tr><tr><td>Bicarbonate</td><td>14 mmol/l</td></tr><tr><td>Urea</td><td>18.2 mmol/l</td></tr><tr><td>Creatinine</td><td>230 \u00b5mol/l</td></tr></tbody></table></div><br />The ECG is shown below:<br /><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg055b.jpg'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg055.jpg'/></a></td></tr><tr><td valign='top' align='left'> <span style = 'font-size:11px; color:LightGray;'>&copy; Image used on license from </span><a href='http://hqmeded-ecg.blogspot.com/'  target='_blank' style = 'font-size:11px; color:LightGray;' >Dr Smith, University of Minnesota</a></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg055b.jpg'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a><a  border='0' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg055c.jpg'  \n\t\ttarget='_blank' ><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass2.png'/></a></td></tr></table></CENTER><br />What is the most appropriate initial management?",
            "",
            ""
        ],
        "answers": [
            "5",
            "",
            ""
        ],
        "notes": [
            "This patient is hyperkalaemic and has associated ECG changes (peaked T waves in the anterior leads and bradycardia). Bradycardia in such patients is a worrying sign as asystole may occur. The first priority in this patient is to stabilise the myocardium with intravenous calcium gluconate.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 45-year-old man is seen in the Emergency Department with nausea, pallor and lethargy. He has no past medical history of note. A cannula is inserted and bloods show the following<br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>Na<sup>+</sup></td><td>140 mmol/l</td></tr><tr><td>K<sup>+</sup></td><td>6.7 mmol/l</td></tr><tr><td>Bicarbonate</td><td>14 mmol/l</td></tr><tr><td>Urea</td><td>18.2 mmol/l</td></tr><tr><td>Creatinine</td><td>230 \u00b5mol/l</td></tr></tbody></table></div><br />The ECG is shown below:<br /><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg055b.jpg'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg055.jpg'/></a></td></tr><tr><td valign='top' align='left'> <span style = 'font-size:11px; color:LightGray;'>&copy; Image used on license from </span><a href='http://hqmeded-ecg.blogspot.com/'  target='_blank' style = 'font-size:11px; color:LightGray;' >Dr Smith, University of Minnesota</a></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg055b.jpg'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a><a  border='0' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg055c.jpg'  \n\t\ttarget='_blank' ><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass2.png'/></a></td></tr></table></CENTER><br />What is the most appropriate initial management?",
        "correct_answer": "5",
        "question_notes": "This patient is hyperkalaemic and has associated ECG changes (peaked T waves in the anterior leads and bradycardia). Bradycardia in such patients is a worrying sign as asystole may occur. The first priority in this patient is to stabilise the myocardium with intravenous calcium gluconate.",
        "answer_order": "5",
        "answer": "5",
        "title": "Hyperkalaemia: management",
        "body": "Untreated hyperkalaemia may cause life-threatening arrhythmias. Precipitating factors should be addressed (e.g. acute kidney injury) and aggravating drugs stopped (e.g. ACE inhibitors). Management may be categorised by the aims of treatment<br /><br /><h5 class='notes-heading'>Staging</h5><br />The European Resuscitation Council classifies hyperkalaemia as:<br /><ul><li>mild: 5.5 - 5.9 mmol/L</li><li>moderate:  6.0 - 6.4 mmol/L </li><li>severe: <span class=\"concept\" data-cid=\"11386\">\u2265 6.5 mmol/L</span></li></ul><br />Remember that the presence of <span class=\"concept\" data-cid=\"11385\">ECG</span> changes is important in determining the management - it should be done in all patients with new hyperkalaemia. The following changes are associated with hyperkalaemia:<br /><ul><li>peaked or 'tall-tented' T waves (occurs first)</li><li>loss of P waves</li><li>broad QRS complexes</li><li>sinusoidal wave pattern</li></ul><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg080c.png\" data-fancybox=\"gallery\" data-caption=\"ECG showing severe hyperkalaemia: QRS widening and peaked T waves\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg080.png\" alt=\"\" /></a></div></div></div><br /><h5 class='notes-heading'>Management</h5><br /><h6 class='notes-subheading'>Principles of treatment modalities</h6><br /><span class=\"concept\" data-cid=\"2650\">Stabilisation of the cardiac membrane</span><br /><ul><li>IV calcium gluconate<ul><li><span class=\"concept\" data-cid=\"3364\"> does NOT lower serum potassium levels</span></li></ul></li></ul><br /><span class=\"concept\" data-cid=\"8765\">Short-term shift in potassium from extracellular (ECF) to intracellular fluid (ICF) <br />compartment</span><br /><ul><li>combined insulin/dextrose infusion</li><li>nebulised salbutamol</li></ul><br /><span class=\"concept\" data-cid=\"11233\">Removal of potassium from the body</span><br /><ul><li>calcium resonium (orally or enema)<ul><li><span class=\"concept\" data-cid=\"3363\">enemas are more effective than oral as potassium is secreted by the rectum</span></li></ul></li><li>loop diuretics</li><li>dialysis<ul><li><span class=\"concept\" data-cid=\"2671\">haemofiltration/haemodialysis should be considered for patients with AKI with persistent hyperkalaemia</span></li></ul></li></ul><br />Newer agents<br /><ul><li><span class=\"concept\" data-cid=\"12553\">sodium zirconium cyclosilicate</span><ul><li>non-absorbed inorganic cation exchanger that selectively traps potassium ions in exchange for sodium and hydrogen in the gastrointestinal tract</li><li>acts mainly in the distal small intestine and colon, where potassium concentration is highest</li><li>unlike older resins (e.g. sodium polystyrene sulfonate/Resonium), it has better selectivity, faster onset, and improved tolerability</li></ul></li></ul><br /><h6 class='notes-subheading'>Outline of practical treatment</h6><br />All patients with <span class=\"concept\" data-cid=\"11387\">severe hyperkalaemia (\u2265 6.5 mmol/L) or with ECG changes should have emergency treatment</span><br /><ul><li><b>IV calcium gluconate</b>: to stabilise the myocardium</li><li><b>insulin/dextrose infusion</b>: short-term shift in potassium from ECF to ICF</li><li>other treatments such as nebulised salbutamol may be given to temporarily lower the serum potassium</li></ul><br />Further management<br /><ul><li>stop exacerbating drugs e.g. ACE inhibitors</li><li>treat any underlying cause</li><li>lower total body potassium<ul><li>calcium resonium</li><li>loop diuretics</li><li>dialysis</li></ul></li></ul>",
        "notes_hash": "afb7ec77ad7183dce39cdae0fa31fac7",
        "knowledge_graph_node_id_link": 10293,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "6912",
        "up_votes": "43",
        "down_votes": "8",
        "column_array": [
            0,
            "114",
            "47",
            "93",
            "419",
            "6239",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>UK Renal Association </td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1182\" data-linkid=\"1182\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1182\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"link_dislike_1182\" data-linkid=\"1182\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1182\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">11</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%20-%20JULY%202022%20V2_0.pdf\">Hyperkalemia: management</a></td></tr></table><br><br><table style='width:100%'><tr><td>Patient.info</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1181\" data-linkid=\"1181\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1181\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">16</span><button type=\"button\" style=\"\" id=\"link_dislike_1181\" data-linkid=\"1181\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1181\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://patient.info/doctor/hyperkalaemia-in-adults\">Management of hyperkalaemia</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/f/f2/Hyperkalemia.webm\" data-description=\"Hyperkalemia\" data-upvotes=\"1\" data-downvotes=\"0\" data-media=\"19\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/css/images/osmosis.png\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/f/f2/Hyperkalemia.webm\" data-description=\"Hyperkalemia\" data-upvotes=\"1\" data-downvotes=\"0\" data-media=\"19\">Hyperkalemia</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_41\" data-mediaid=\"41\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_41\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_41\" data-mediaid=\"41\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_41\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/wrij_7e5OrQ\" data-description=\"Understanding Hyperkalaemia (High Potassium)\" data-upvotes=\"0\" data-downvotes=\"1\" data-media=\"1499\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/wrij_7e5OrQ/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/wrij_7e5OrQ\" data-description=\"Understanding Hyperkalaemia (High Potassium)\" data-upvotes=\"0\" data-downvotes=\"1\" data-media=\"1499\">Understanding Hyperkalaemia (High Potassium)</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2641\" data-mediaid=\"2641\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2641\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_2641\" data-mediaid=\"2641\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2641\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 5,
        "concepts_for_notes": {
            "2650": {
                "concept_text": "Hyperkalaemia + ECG changes: IV calcium gluconate is given first for stabilisation of the cardiac membrane",
                "concept_percentile": "68"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "9290_B_7",
        "new_question_id": "20312",
        "question_type": "0",
        "category": "2",
        "concept_id_link": "10047",
        "notes_id_link": "1_1378",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Chloramphenicol eye ointment",
            "Apply warm compresses to eye",
            "Recommend saline eye baths",
            "Reassurance",
            "Urgent referral to ophthalmology",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 6-year-old girl presents to GP with a number of small, circular lesions located mainly on trunk and arms. These have been present for around 10 days. The child is otherwise fit and well with no past medical history and no regular medications.<br /><br />Examination shows a number of well-demarcated, umbilicated lesions around 5mm in diameter which are present on the torso and the upper limbs. There are also some lesions on the right eyelid, with associated reddening of the eye.<br /><br />Given the likely diagnosis, what is the most appropriate management of the child's eye symptoms?",
            "",
            ""
        ],
        "answers": [
            "5",
            "0",
            "0"
        ],
        "notes": [
            "Molluscum contagiosum cause a conjunctivitis or keratitis that can be serious and threaten eyesight if not reviewed promptly and managed appropriately.<br /><br />The other options are all inappropriate at this stage.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 6-year-old girl presents to GP with a number of small, circular lesions located mainly on trunk and arms. These have been present for around 10 days. The child is otherwise fit and well with no past medical history and no regular medications.<br /><br />Examination shows a number of well-demarcated, umbilicated lesions around 5mm in diameter which are present on the torso and the upper limbs. There are also some lesions on the right eyelid, with associated reddening of the eye.<br /><br />Given the likely diagnosis, what is the most appropriate management of the child's eye symptoms?",
        "correct_answer": "5",
        "question_notes": "Molluscum contagiosum cause a conjunctivitis or keratitis that can be serious and threaten eyesight if not reviewed promptly and managed appropriately.<br /><br />The other options are all inappropriate at this stage.",
        "answer_order": "5",
        "answer": "5",
        "title": "Molluscum contagiosum",
        "body": "Molluscum contagiosum is a common skin infection caused by molluscum contagiosum virus (MCV), a member of the <span class=\"concept\" data-cid=\"11963\">Poxviridae family</span>. Transmission occurs directly by close personal contact, or indirectly via fomites (contaminated surfaces) such as shared towels and flannels. The majority of cases occur in children (often in children with atopic eczema), with the maximum incidence in preschool children aged 1-4 years.<br /><br />Typically, molluscum contagiosum presents with characteristic pinkish or pearly white papules with a central umbilication, which are up to 5 mm in diameter. Lesions appear in clusters in areas anywhere on the body (except the palms of the hands and the soles of the feet). In children, lesions are commonly seen on the trunk and in flexures, but anogenital lesions may also occur. In adults, sexual contact may lead to lesions developing on the genitalia, pubis, thighs, and lower abdomen. Rarely, lesions can occur on the oral mucosa and on the eyelids.<br /><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/dsd121b.jpg\" data-fancybox=\"gallery\" data-caption=\"Molluscum contagiosum . Image used on license from DermNet NZ and with the kind permission of Prof Raimo Suhonen\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/dsd121.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd946.jpg\" data-fancybox=\"gallery\" data-caption=\"Molluscum contagiosum in a child. The image demonstrates the typical pearly papules with umbilicated centres\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd946.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd122b.jpg\" data-fancybox=\"gallery\" data-caption=\"Molluscum contagiosum. Image used on license from DermNet NZ\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd122.jpg\" alt=\"\" /></a></div></div></div><br />Self-care advice:<br /><ul><li>Reassure people that molluscum contagiosum is a self-limiting condition.</li><li>Spontaneous resolution usually occurs within 18 months</li><li>Explain that lesions are contagious, and it is sensible to avoid sharing towels, clothing, and baths with uninfected people (e.g. siblings)</li><li>Encourage people not to scratch the lesions. If it is problematic, consider treatment to alleviate the itch</li><li><span class=\"concept\" data-cid=\"3834\">Exclusion from school, gym, or swimming is not necessary</span></li></ul><br /><span class=\"concept\" data-cid=\"11586\">Treatment is not usually recommended</span>. If lesions are troublesome or considered unsightly, use simple trauma or cryotherapy, depending on the parents' wishes and the child's age:<br /><ul><li>Squeezing (with fingernails) or piercing (orange stick) lesions may be tried, following a bath. Treatment should be limited to a few lesions at one time</li><li>Cryotherapy may be used in older children or adults, if the healthcare professional is experienced in the procedure</li><li>Eczema or inflammation can develop around lesions prior to resolution. Treatment may be required if:<ul><li>Itching is problematic; prescribe an emollient and a mild topical corticosteroid (e.g. hydrocortisone 1%)</li><li>The skin looks infected (e.g. oedema, crusting); prescribe a topical antibiotic (e.g. fusidic acid 2%)</li></ul></li></ul><br />Referral may be necessary in some circumstances:<br /><ul><li>For people who are <span class=\"concept\" data-cid=\"9114\">HIV-positive with extensive lesions</span>  urgent referral to a HIV specialist</li><li><span class=\"concept\" data-cid=\"10047\">For people with eyelid-margin or ocular lesions and associated red eye urgent referral to an ophthalmologist</span></li><li>Adults with anogenital lesions should be referred to genito-urinary medicine, for screening for other sexually transmitted infections</li></ul>",
        "notes_hash": "6b45b8717155c2630b232742478984f9",
        "knowledge_graph_node_id_link": 11097,
        "concept": "Molluscum contagiosum with eyelid or ocular involvement and red eye requires urgent ophthalmology review ",
        "concept_percentile": "71",
        "concept_colour": "rgb(147,255,0)",
        "number_attempts": "6239",
        "up_votes": "52",
        "down_votes": "7",
        "column_array": [
            0,
            "287",
            "422",
            "92",
            "1585",
            "3853",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>DermNet NZ</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1120\" data-linkid=\"1120\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1120\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">14</span><button type=\"button\" style=\"\" id=\"link_dislike_1120\" data-linkid=\"1120\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1120\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://www.dermnetnz.org/topics/molluscum-contagiosum/\">Molluscum contagiosum</a></td></tr></table>",
        "media": "",
        "comment_count": 4,
        "concepts_for_notes": {
            "10047": {
                "concept_text": "Molluscum contagiosum with eyelid or ocular involvement and red eye requires urgent ophthalmology review ",
                "concept_percentile": "71"
            },
            "11586": {
                "concept_text": "Molluscum contagiosum in children - treatment is not usually recommended.",
                "concept_percentile": "99"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1684",
        "new_question_id": "5665",
        "question_type": "0",
        "category": "2",
        "concept_id_link": "0",
        "notes_id_link": "1_1895",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Vitiligo",
            "Carbimazole-induced hypopigmentation",
            "Leukopaenia-induced fungal infection",
            "Idiopathic guttate hypomelanosis",
            "Addison disease",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 45-year-old woman presents for review. She has noticed a number of patches of 'pale skin' on her hands over the past few weeks. The patient has tried using an emollient and topical hydrocortisone with no result. On examination, you note a number of depigmented patches on the dorsum of both hands. Her past medical history includes thyrotoxicosis for which she takes carbimazole and thyroxine. <br /><br />What is the most likely cause of her symptoms?",
            "",
            ""
        ],
        "answers": [
            "1",
            "0",
            "0"
        ],
        "notes": [
            "<b>Vitiligo</b> is the correct answer. This autoimmune condition causes patches of depigmented skin due to destruction of melanocytes. The presentation of symmetrical, well-demarcated depigmented patches on the dorsum of hands is classic for vitiligo. Furthermore, the patient has thyrotoxicosis, and there is a strong association between vitiligo and other autoimmune conditions, particularly thyroid disorders. The lack of response to topical steroids and emollients is also consistent with vitiligo.<br /><br /><b>Carbimazole-induced hypopigmentation</b> is incorrect. While carbimazole can cause various side effects, hypopigmentation is not a recognised adverse effect. The main side effects of carbimazole include agranulocytosis, rash, arthralgia, and hepatotoxicity.<br /><br /><b>Leukopaenia-induced fungal infection</b> is incorrect. Although carbimazole can cause leukopaenia, which could theoretically predispose to fungal infections, fungal infections typically present with scaling, erythema, and pruritus rather than simple depigmentation. Additionally, fungal infections would likely respond, at least partially, to topical treatments.<br /><br /><b>Idiopathic guttate hypomelanosis</b> is incorrect. While this condition does cause hypopigmented macules, it typically affects sun-exposed areas and presents as small (2-5mm), round, porcelain-white macules. It is also more common in older individuals and tends to develop gradually over years rather than weeks.<br /><br /><b>Addison disease</b> is incorrect. Addison disease causes hyperpigmentation rather than hypopigmentation due to increased ACTH levels. Additionally, there are no other symptoms suggestive of adrenal insufficiency such as fatigue, postural hypotension, or salt craving.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 45-year-old woman presents for review. She has noticed a number of patches of 'pale skin' on her hands over the past few weeks. The patient has tried using an emollient and topical hydrocortisone with no result. On examination, you note a number of depigmented patches on the dorsum of both hands. Her past medical history includes thyrotoxicosis for which she takes carbimazole and thyroxine. <br /><br />What is the most likely cause of her symptoms?",
        "correct_answer": "1",
        "question_notes": "<b>Vitiligo</b> is the correct answer. This autoimmune condition causes patches of depigmented skin due to destruction of melanocytes. The presentation of symmetrical, well-demarcated depigmented patches on the dorsum of hands is classic for vitiligo. Furthermore, the patient has thyrotoxicosis, and there is a strong association between vitiligo and other autoimmune conditions, particularly thyroid disorders. The lack of response to topical steroids and emollients is also consistent with vitiligo.<br /><br /><b>Carbimazole-induced hypopigmentation</b> is incorrect. While carbimazole can cause various side effects, hypopigmentation is not a recognised adverse effect. The main side effects of carbimazole include agranulocytosis, rash, arthralgia, and hepatotoxicity.<br /><br /><b>Leukopaenia-induced fungal infection</b> is incorrect. Although carbimazole can cause leukopaenia, which could theoretically predispose to fungal infections, fungal infections typically present with scaling, erythema, and pruritus rather than simple depigmentation. Additionally, fungal infections would likely respond, at least partially, to topical treatments.<br /><br /><b>Idiopathic guttate hypomelanosis</b> is incorrect. While this condition does cause hypopigmented macules, it typically affects sun-exposed areas and presents as small (2-5mm), round, porcelain-white macules. It is also more common in older individuals and tends to develop gradually over years rather than weeks.<br /><br /><b>Addison disease</b> is incorrect. Addison disease causes hyperpigmentation rather than hypopigmentation due to increased ACTH levels. Additionally, there are no other symptoms suggestive of adrenal insufficiency such as fatigue, postural hypotension, or salt craving.",
        "answer_order": "1",
        "answer": "1",
        "title": "Vitiligo",
        "body": "Vitiligo is an autoimmune condition which results in the loss of melanocytes and consequent depigmentation of the skin. It is thought to affect around 1% of the population and symptoms typically develop by the age of 20-30 years.<br /><br />Associated conditions<br /><ul><li>type 1 diabetes mellitus</li><li>Addison's disease</li><li>autoimmune thyroid disorders</li><li>pernicious anaemia</li><li>alopecia areata</li></ul><br />Features<br /><ul><li>well-demarcated patches of depigmented skin</li><li>the peripheries tend to be most affected</li><li>trauma may precipitate new lesions (Koebner phenomenon)</li></ul><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd029b.jpg\" data-fancybox=\"gallery\" data-caption=\"Vitiligo\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd029.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd960b.jpg\" data-fancybox=\"gallery\" data-caption=\"Vitiligo\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd960.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd030b.jpg\" data-fancybox=\"gallery\" data-caption=\"Vitiligo\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd030.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd031b.jpg\" data-fancybox=\"gallery\" data-caption=\"Vitiligo\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd031.jpg\" alt=\"\" /></a></div></div></div><br />Management<br /><ul><li>sunblock for affected areas of skin</li><li>camouflage make-up</li><li>topical corticosteroids may reverse the changes if applied early</li><li>there may also be a role for topical tacrolimus and phototherapy, although caution needs to be exercised with light-skinned patients</li></ul>",
        "notes_hash": "217a854dbff5787210d74142a61d9294",
        "knowledge_graph_node_id_link": 1373,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "5814",
        "up_votes": "36",
        "down_votes": "14",
        "column_array": [
            0,
            "4298",
            "1104",
            "157",
            "111",
            "144",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>DermNet NZ</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_776\" data-linkid=\"776\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_776\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">11</span><button type=\"button\" style=\"\" id=\"link_dislike_776\" data-linkid=\"776\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_776\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">7</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.dermnetnz.org/topics/vitiligo/\">Vitiligo</a></td></tr></table>",
        "media": "",
        "comment_count": 5,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "12729_B_263",
        "new_question_id": "55356",
        "question_type": "0",
        "category": "11",
        "concept_id_link": "669",
        "notes_id_link": "1_387",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Breastfeeding is contraindicated with all antiepileptic drugs",
            "Continue carbamazepine and start breastfeeding",
            "Stop carbamazepine and start breastfeeding",
            "Switch to primidone and start breastfeeding",
            "Switch to topiramate and start breastfeeding",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 30-year-old woman is considering breastfeeding her newborn. She has a past medical history of epilepsy, which is well-controlled on carbamazepine. She asks whether it is safe to breastfeed while on her medication.<br /><br />What is the most appropriate advice to give her?",
            "",
            ""
        ],
        "answers": [
            "2",
            "0",
            "0"
        ],
        "notes": [
            "<b> Continue carbamazepine and start breastfeeding </b> is the correct advice to give this mother. Carbamazepine is considered safe for breastfeeding. Although it does pass into breast milk, the levels are typically low and not associated with adverse effects in breastfed infants. Regular monitoring of the infant, particularly for drowsiness, poor feeding, or jaundice, however, is advisable. The benefits of breastfeeding often outweigh the risks of continuing this medication.<br /><br /><b> Breastfeeding is contraindicated with all antiepileptic drugs </b> is incorrect. Breastfeeding is generally considered safe with most antiepileptic medications, including carbamazepine, lamotrigine and sodium valproate. However, for antiepileptics such as primidone and phenobarbital, caution is advised due to their potential for sedative effects in the infant. Other medications, such as topiramate, should also be avoided during breastfeeding due to the risk of higher drug levels passing into breast milk and potential adverse effects on the infant.<br /><br /><b> Stop carbamazepine and start breastfeeding </b> is not safe. Stopping carbamazepine can increase the risk of seizure activity in the mother, which could pose risks to both her and the newborn. <br /><br /><b> Switch to primidone and start breastfeeding </b> is incorrect. Primidone passes into breast milk and can cause sedative effects in the baby. Carbamazepine is a much safer alternative; therefore, this is not appropriate advice. <br /><br /><b> Switch to topiramate and start breastfeeding </b> is incorrect. The BNF states that topiramate should be avoided when breastfeeding as it passes into breast milk.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 30-year-old woman is considering breastfeeding her newborn. She has a past medical history of epilepsy, which is well-controlled on carbamazepine. She asks whether it is safe to breastfeed while on her medication.<br /><br />What is the most appropriate advice to give her?",
        "correct_answer": "2",
        "question_notes": "<b> Continue carbamazepine and start breastfeeding </b> is the correct advice to give this mother. Carbamazepine is considered safe for breastfeeding. Although it does pass into breast milk, the levels are typically low and not associated with adverse effects in breastfed infants. Regular monitoring of the infant, particularly for drowsiness, poor feeding, or jaundice, however, is advisable. The benefits of breastfeeding often outweigh the risks of continuing this medication.<br /><br /><b> Breastfeeding is contraindicated with all antiepileptic drugs </b> is incorrect. Breastfeeding is generally considered safe with most antiepileptic medications, including carbamazepine, lamotrigine and sodium valproate. However, for antiepileptics such as primidone and phenobarbital, caution is advised due to their potential for sedative effects in the infant. Other medications, such as topiramate, should also be avoided during breastfeeding due to the risk of higher drug levels passing into breast milk and potential adverse effects on the infant.<br /><br /><b> Stop carbamazepine and start breastfeeding </b> is not safe. Stopping carbamazepine can increase the risk of seizure activity in the mother, which could pose risks to both her and the newborn. <br /><br /><b> Switch to primidone and start breastfeeding </b> is incorrect. Primidone passes into breast milk and can cause sedative effects in the baby. Carbamazepine is a much safer alternative; therefore, this is not appropriate advice. <br /><br /><b> Switch to topiramate and start breastfeeding </b> is incorrect. The BNF states that topiramate should be avoided when breastfeeding as it passes into breast milk.",
        "answer_order": "2",
        "answer": "2",
        "title": "Epilepsy: pregnancy and breast feeding",
        "body": "The risks of uncontrolled epilepsy during pregnancy generally outweigh the risks of medication to the fetus. All women thinking about becoming pregnant should be advised to take folic acid 5mg per day well before pregnancy to minimise the risk of neural tube defects. Around 1-2% of newborns born to non-epileptic mothers have congenital defects. This rises to 3-4% if the mother takes antiepileptic medication.<br /><br />Other points<br /><ul><li>aim for monotherapy</li><li>there is no indication to monitor antiepileptic drug levels</li><li>sodium valproate: associated with neural tube defects</li><li>carbamazepine: often considered the least teratogenic of the older antiepileptics</li><li>phenytoin: associated with cleft palate</li><li>lamotrigine: studies to date suggest the rate of congenital malformations may be low. The dose of lamotrigine may need to be increased in pregnancy</li></ul><br /><span class=\"concept\" data-cid=\"669\">Breast feeding is generally considered safe for mothers taking antiepileptics</span> with the possible exception of the barbiturates<br /><br />It is advised that pregnant women taking phenytoin are given vitamin K in the last month of pregnancy to prevent clotting disorders in the newborn<br /><br /><h5 class='notes-heading'>Sodium valproate</h5><br />The November 2013 issue of the Drug Safety Update also carried a warning about new evidence showing a significant risk of neurodevelopmental delay in children following maternal use of sodium valproate.<br /><br />The update concludes that sodium valproate should not be used during pregnancy and in women of childbearing age unless clearly necessary. Women of childbearing age should not start treatment without specialist neurological or psychiatric advice.",
        "notes_hash": "804fff819c3352ec261391c6f59e7267",
        "knowledge_graph_node_id_link": 11266,
        "concept": "Breast feeding is acceptable with nearly all anti-epileptic drugs",
        "concept_percentile": "94",
        "concept_colour": "rgb(30,255,0)",
        "number_attempts": "5837",
        "up_votes": "2",
        "down_votes": "1",
        "column_array": [
            0,
            "446",
            "4755",
            "156",
            "208",
            "272",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>SIGN</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_129\" data-linkid=\"129\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_129\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">7</span><button type=\"button\" style=\"\" id=\"link_dislike_129\" data-linkid=\"129\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_129\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.sign.ac.uk/media/1079/sign143_2018.pdf\">2018 Diagnosis and management of epilepsy in adults</a></td></tr></table><br><br><table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_120\" data-linkid=\"120\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_120\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">10</span><button type=\"button\" style=\"\" id=\"link_dislike_120\" data-linkid=\"120\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_120\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng217\">2022 Epilepsy guidelines</a></td></tr></table><br><br><table style='width:100%'><tr><td>Royal College of Obstetricians and Gynaecologists</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1242\" data-linkid=\"1242\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1242\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">7</span><button type=\"button\" style=\"\" id=\"link_dislike_1242\" data-linkid=\"1242\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1242\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.rcog.org.uk/globalassets/documents/guidelines/green-top-guidelines/gtg68_epilepsy.pdf\">2016 Epilepsy in Pregnancy</a></td></tr></table>",
        "media": "",
        "comment_count": 1,
        "concepts_for_notes": {
            "669": {
                "concept_text": "Breast feeding is acceptable with nearly all anti-epileptic drugs",
                "concept_percentile": "94"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1585",
        "new_question_id": "4587",
        "question_type": "0",
        "category": "2",
        "concept_id_link": "0",
        "notes_id_link": "1_1779",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Linear IgA dermatosis",
            "Neurotic excoriations",
            "Scabies",
            "Dermatitis herpetiformis",
            "SSRI-associated dermatitis",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 27-year-old man with a history of depression and coeliac disease presents with an itchy rash on his buttocks:<br /><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd054b.jpg'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd054.jpg'/></a></td></tr><tr><td valign='top' align='left'> <span style = 'font-size:11px; color:LightGray;'>&copy; Image used on license from </span><a href='http://www.dermnet.org.nz'  target='_blank' style = 'font-size:11px; color:LightGray;' >DermNet NZ</a></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd054b.jpg'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><br />What is the most likely diagnosis?",
            "",
            ""
        ],
        "answers": [
            "4",
            "",
            ""
        ],
        "notes": [
            "The correct answer is <b>Dermatitis herpetiformis</b>. Dermatitis herpetiformis is a chronic, intensely pruritic skin disease characterised by grouped erythematous papules, vesicles and bullae. It is associated with coeliac disease, which the patient has a history of. The rash typically involves extensor surfaces such as the buttocks, elbows and knees. The diagnosis can be confirmed by skin biopsy showing granular IgA deposits at the dermo-epidermal junction.<br /><br /><b>Linear IgA dermatosis</b> is an uncommon autoimmune blistering disorder that presents with tense blisters on normal or erythematous skin. It is not specifically linked to coeliac disease and while it can affect any body site, it favours the trunk and lower extremities rather than specifically the buttocks.<br /><br /><b>Neurotic excoriations</b> refer to self-inflicted skin lesions produced by repetitive scratching. They are often seen in patients with psychiatric conditions including depression but tend to be more widespread and do not have the characteristic appearance of dermatitis herpetiformis.<br /><br /><b>Scabies</b> could present with an itching rash on the buttocks, however, scabies tends to cause more generalised itch especially in web spaces of fingers, wrists and ankles. The clinical picture would also usually include burrows or nodules which are not described here.<br /><br />Lastly, <b>SSRI-associated dermatitis</b> refers to skin reactions related to selective serotonin reuptake inhibitors (SSRIs), a class of drugs commonly used in treating depression. While SSRIs can cause various skin reactions including rashes and pruritus, these tend to be more diffuse rather than localised solely on the buttocks as in this case scenario.<br /><br />Therefore based on the clinical presentation and the patient's history of coeliac disease, Dermatitis herpetiformis represents the most likely diagnosis.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 27-year-old man with a history of depression and coeliac disease presents with an itchy rash on his buttocks:<br /><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd054b.jpg'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd054.jpg'/></a></td></tr><tr><td valign='top' align='left'> <span style = 'font-size:11px; color:LightGray;'>&copy; Image used on license from </span><a href='http://www.dermnet.org.nz'  target='_blank' style = 'font-size:11px; color:LightGray;' >DermNet NZ</a></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd054b.jpg'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><br />What is the most likely diagnosis?",
        "correct_answer": "4",
        "question_notes": "The correct answer is <b>Dermatitis herpetiformis</b>. Dermatitis herpetiformis is a chronic, intensely pruritic skin disease characterised by grouped erythematous papules, vesicles and bullae. It is associated with coeliac disease, which the patient has a history of. The rash typically involves extensor surfaces such as the buttocks, elbows and knees. The diagnosis can be confirmed by skin biopsy showing granular IgA deposits at the dermo-epidermal junction.<br /><br /><b>Linear IgA dermatosis</b> is an uncommon autoimmune blistering disorder that presents with tense blisters on normal or erythematous skin. It is not specifically linked to coeliac disease and while it can affect any body site, it favours the trunk and lower extremities rather than specifically the buttocks.<br /><br /><b>Neurotic excoriations</b> refer to self-inflicted skin lesions produced by repetitive scratching. They are often seen in patients with psychiatric conditions including depression but tend to be more widespread and do not have the characteristic appearance of dermatitis herpetiformis.<br /><br /><b>Scabies</b> could present with an itching rash on the buttocks, however, scabies tends to cause more generalised itch especially in web spaces of fingers, wrists and ankles. The clinical picture would also usually include burrows or nodules which are not described here.<br /><br />Lastly, <b>SSRI-associated dermatitis</b> refers to skin reactions related to selective serotonin reuptake inhibitors (SSRIs), a class of drugs commonly used in treating depression. While SSRIs can cause various skin reactions including rashes and pruritus, these tend to be more diffuse rather than localised solely on the buttocks as in this case scenario.<br /><br />Therefore based on the clinical presentation and the patient's history of coeliac disease, Dermatitis herpetiformis represents the most likely diagnosis.",
        "answer_order": "4",
        "answer": "4",
        "title": "Dermatitis herpetiformis",
        "body": "Dermatitis herpetiformis is an autoimmune blistering skin disorder associated with <span class=\"concept\" data-cid=\"9304\">coeliac disease</span>. It is caused by <span class=\"concept\" data-cid=\"434\">deposition of IgA in the dermis</span>. More than 90% of patients exhibit small bowel biopsy findings consistent with some degree of gluten-sensitive enteropathy.<br /><br />Features<br /><ul><li>itchy, vesicular skin lesions on the extensor surfaces (e.g. elbows, knees, buttocks)</li></ul><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd955b.jpg\" data-fancybox=\"gallery\" data-caption=\"Dermatitis herpetiformis in a young male who presented with a bilateral, symmetrical, intensely pruritic papulovesicular rash. Image used on license from DermNet NZ\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd955.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/dsx053.jpg\" data-fancybox=\"gallery\" data-caption=\"Dermatitis herpetiformis. Image used on license from DermNet NZ and with the kind permission of Prof Raimo Suhonen\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/dsx053.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd956b.jpg\" data-fancybox=\"gallery\" data-caption=\"Dermatitis herpetiformis in a middle-aged female who presented with pruritic vesicles on her knees and elbows. Image used on license from DermNet NZ\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd956.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd054b.jpg\" data-fancybox=\"gallery\" data-caption=\"Dermatitis herpetiformis. Image used on license from DermNet NZ\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd054.jpg\" alt=\"\" /></a></div></div></div><br />Diagnosis<br /><ul><li><span class=\"concept\" data-cid=\"11803\">skin biopsy</span>: direct immunofluorescence shows deposition of IgA in a granular pattern in the upper dermis</li></ul><br /><span class=\"concept\" data-cid=\"9430\">Management</span><br /><ul><li>gluten-free diet</li><li>dapsone</li></ul>",
        "notes_hash": "c4b038e24221d42862100582692bc950",
        "knowledge_graph_node_id_link": 1274,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "5420",
        "up_votes": "20",
        "down_votes": "7",
        "column_array": [
            0,
            "281",
            "55",
            "124",
            "4856",
            "104",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>DermNet NZ</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_768\" data-linkid=\"768\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_768\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">33</span><button type=\"button\" style=\"\" id=\"link_dislike_768\" data-linkid=\"768\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_768\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.dermnetnz.org/topics/dermatitis-herpetiformis/\">Dermatitis herpetiformis</a></td></tr></table>",
        "media": "",
        "comment_count": 2,
        "concepts_for_notes": {
            "9304": {
                "concept_text": "Dermatitis herpetiformis has a recognised association with coeliac disease",
                "concept_percentile": "29"
            }
        },
        "optimisation_reason": ""
    }
]